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Generalized Morphoea M Feiwel MB MRCP Housewife, aged 57 History: Onset in 1944 with cedema of ankles, then pain and swelling ofvarious joints, increasing tightness and tenderness of skin and general weakness. Was bedridden for several years and inpatient of various hospitals (including Hammersmith and Westminster Hospitals) with diagnosis of generalized scleroderma. Had Investigations: Barium swallow showed normal cesophagus in 1945, 1951 and 1957 . Chest X-ray normal. Hands show some soft tissue calcifications. ECG showed various abnormalities but these were without precise significance. Renal biopsy normal. Serum proteins: total 8-2, albumin 4 0, globulin 4-2 g/100 ml, electrophoresis showed some increase in globulin. Antinuclear factor, spot test, negative.
Comment: The patient is presented twenty years after onset of disease. Members may accept the term generalized morphoea for this type of diffuse scleroderma where the whole integument becomes involved (Figs 1 and 2), in which systemic changes are absent or extremely rare and where, once the patient has survived the sclerotic phase of the disorder, the prognosis is good.
My patient has mainly been under the care of general physicians (though Dr Lipman Cohen has also looked after her). They have not differentiated her case from those sclerodermas with systemic manifestations. The many investigations including a renal biopsy suggest that such changes were expected as well as possibly a downhill course. However, apart from diabetes which is probably incidental, there is no evidence of internal disease and the patient is improving steadily. In generalized morphoea the skin change although widespread over the body is analogous to that occurring in the more circumscribed forms. Sclerosis after a variable interval may remit partially or completely. My patient's skin is now much less rigid (Fig 3) .
In this country it is usually emphasized that scleroderma with visceral manifestations has cutaneous change of a characteristic restricted peripheral distribution (Dowling 1955 (Dowling , 1958 . Hutchinson (1896) termed this acrosclerodermia and Sellei (1934) called it acrosclerosis. Limited skin involvement associated with widespread visceral disease induced Goetz (1945) to propose that the syndrome be called progressive systemic sclerosis.
A distinction of generalized morphoea from systemic scleroderma based on the pattern of skin involvement comes up against the views of the Mayo Clinic workers. Thus, Tuffanelli & Winkelmann (1961) were still describing diffuse scleroderma as 'a rare condition characterized by generalized cutaneous sclerosis, usually beginning centrally and often sparing the extremities. Raynaud's phenomenon is absent. Systemic manifestations are common and are similar to those seen in acrosclerosis. The course is rapid. The prognosis is extremely poor'. Of 727 cases of systemic scleroderma analysed by Tuffanelli & Winkelmann 5*4 % were of this central type. Jablonska et al. (1962) also reported patients with systemic involvement in whom the entire skin was affected. In my limited experience systemic scleroderma has always shown the acrosclerodermatous pattern of cutaneous change. When the clinical picture has been that of generalized morphcea as in my patient, systemic disease has been absent. Derm., Chicago 84, 359 Dr E Lipman Cohen: I have known this patient for more than twenty years. At the end of the war she was completely confined to bed and was almost immobile with sclerodermatous facies. Improvement has been gradual but steady. X-rays have shown much calcium in the soft tissues. The diagnoses are Thibierge-Weissenbach syndrome and diabetes mellitus. The unique feature has been the coincidence of this syndrome with pyodermatitis vegetans of the Azua type affecting one hand; the lesion was successfully removed by a surgeon. DrW B Reed: O'Leary & Waisman (1943, Arch. Derm. Syph., Chicago 47, 382) and Tuffanelli & Winkelmann (1962, Ann. intern. Med. 57, 198 ) described a type of scleroderma with a central distribution in contrast to the type called acrosclerosis. Tuffanelli had about twenty patients (not reported) with generalized morphoea without systemic involvements. However, there may be systemic involvements with generalized morphera (Curtis & Jansen, 1958, Arch. Derm., Chicago 78, 749) . I believe that there are a few patients with generalized morphoea who develop systemic changes similar to what is noted with discoid lupus erythematosus.
Dr M Feiwel: Dysphagia in my patient was probably part of her general difficulties resulting from cutaneous sclerosis.
The syndrome of calcinosis with scleroderma as described by Thibierge & Weissenbach (1910) refers to the systemic disorder as in a case shown previously (Firth et al. 1956 ). Reports of systemic manifestations in morpheea (Donaldson 1962 , Curtis & Jansen 1958 are uncommon. Prognosis in generalized morphoea was discussed when Gold (1956) showed a case. The prognosis appears to be good in the patient presented today.
The following cases were also shown: Chronic Monocytic Leukemia with Necrosis 
